1. Home
  2. SPRY vs DRH Comparison

SPRY vs DRH Comparison

Compare SPRY & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • DRH
  • Stock Information
  • Founded
  • SPRY 2015
  • DRH 2004
  • Country
  • SPRY United States
  • DRH United States
  • Employees
  • SPRY N/A
  • DRH N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • DRH Real Estate Investment Trusts
  • Sector
  • SPRY Health Care
  • DRH Real Estate
  • Exchange
  • SPRY Nasdaq
  • DRH Nasdaq
  • Market Cap
  • SPRY 1.4B
  • DRH 1.6B
  • IPO Year
  • SPRY N/A
  • DRH 2005
  • Fundamental
  • Price
  • SPRY $14.16
  • DRH $7.53
  • Analyst Decision
  • SPRY Strong Buy
  • DRH Hold
  • Analyst Count
  • SPRY 4
  • DRH 6
  • Target Price
  • SPRY $28.75
  • DRH $8.79
  • AVG Volume (30 Days)
  • SPRY 1.5M
  • DRH 2.7M
  • Earning Date
  • SPRY 05-14-2025
  • DRH 05-01-2025
  • Dividend Yield
  • SPRY N/A
  • DRH 5.50%
  • EPS Growth
  • SPRY N/A
  • DRH N/A
  • EPS
  • SPRY N/A
  • DRH 0.19
  • Revenue
  • SPRY $97,122,000.00
  • DRH $1,128,313,000.00
  • Revenue This Year
  • SPRY $1.49
  • DRH $0.28
  • Revenue Next Year
  • SPRY $141.68
  • DRH $2.47
  • P/E Ratio
  • SPRY N/A
  • DRH $40.18
  • Revenue Growth
  • SPRY 971120.00
  • DRH 3.73
  • 52 Week Low
  • SPRY $7.55
  • DRH $6.19
  • 52 Week High
  • SPRY $18.51
  • DRH $10.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 50.86
  • DRH 48.83
  • Support Level
  • SPRY $14.32
  • DRH $7.31
  • Resistance Level
  • SPRY $15.50
  • DRH $7.71
  • Average True Range (ATR)
  • SPRY 0.84
  • DRH 0.14
  • MACD
  • SPRY 0.06
  • DRH -0.02
  • Stochastic Oscillator
  • SPRY 65.19
  • DRH 30.56

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: